Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace Positron Emission Tomography (PET/CT)

NCT03846167 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03846167
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03846167 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace Positron Emission Tomography (PET/CT)
Lead sponsor
University of Pennsylvania
Phase
Observational
Overall status
Active, not recruiting
Start date
February 11, 2019
Completion date
February 28, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer